Bidiphar sets revenue target of 2,000 billion VND in 2025

(BD) - In 2025, Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) - one of the "giants" in the Vietnamese pharmaceutical industry, aims to increase its charter capital to VND 1,134 billion, revenue to VND 2,000 billion, and pre-tax profit to VND 335 billion.

The above target was approved by Bidiphar at the 2025 Annual General Meeting of Shareholders, which took place on the morning of April 26 (photo).

Photo: MH

Bidiphar identified that in 2025, the domestic and international context will still have many difficulties, with unpredictable factors. However, setting a higher revenue growth target than the results achieved in 2024 is based on many factors. In particular, it is important to take advantage of competitive advantages to continue to develop market share and revenue of key product groups such as cancer drugs, dialysis solutions, antibiotics, etc. Expanding the distribution system, distributing through diverse sales channels (hospitals, pharmacies, pharmacy chains, e-commerce, export, etc.).

At the same time, research and develop new products and improve existing products to promptly meet customer and market needs, create competitive advantages for the company and implement the criteria of taking quality as the foundation.

In addition, continue to optimize operations through new programs and new ways of doing things to bring higher efficiency at optimal costs. Optimize operations, perfect operating models, organizational structures, create a foundation for applying new, modern, flexible and effective management and business models; redesign work processes, optimize operations based on technology applications, thereby optimizing personnel costs as well as operating costs...

Regarding the 2025 investment plan, Bidiphar continues to add more than 570 billion VND to the Small Volume Sterile Pharmaceutical Factory project. Focusing on investment in digital transformation, production, research; building an office building at 34 Ngo May...

At the General Meeting of Shareholders, evaluating the results of production and business activities in 2024, Bidiphar has strived to achieve a revenue growth of 5% compared to the same period in 2023 and reached 91% of the annual plan, equivalent to 1,817 billion VND. At the same time, achieving a 2% growth in profit compared to the previous year, equivalent to 325 billion VND.

Bidiphar's 2025 General Meeting of Shareholders voted to approve a plan to pay dividends in shares at a rate of 20% for 2024.

MAI HOANG

Source: https://baobinhdinh.vn/viewer.aspx?macm=5&macmp=5&mabb=354998